← Evidence map

ArticleJournal of comparative effectiveness research2024

Cost-effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failure.

Jaehong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38771012